Bankers at major global institutions, including Bank of America, have indicated that Brazil’s IPO pipeline is improving, with expectations of more deals over the next few years, though public forecasts do not specify a concrete number of IPOs or minimum deal size for 2027.
A market thaw, not a full thaw
The domestic market has been frozen for years. Brazil’s B3 exchange went roughly two years without a major traditional IPO after 2021, with the equity capital markets dominated by follow-on offerings rather than new listings. That break matters because local listings set the tone for pricing, liquidity, and investor confidence.
However, the strongest Brazil-linked growth stories have still preferred US venues. Several Brazilian fintechs, such as StoneCo and PagSeguro, have listed in the US, demonstrating that deeper foreign markets continue to attract Brazilian issuers seeking larger capital pools and broader investor reach. Agibank (now Agi) has considered capital markets transactions and a potential listing, but there is no record of a completed US IPO in New York.
That pattern leaves a clear question for institutional investors. Is this a true Brazilian IPO rebound, or simply a rerouting of supply to deeper foreign markets?
Why the home market still matters
A revival at home would signal more than a short-term window. It would suggest that Brazilian issuers can again tap domestic capital at scale, and that local exchanges can compete on valuation and execution. The improving pipeline points to a broader set of potential listings, not just one or two isolated transactions.
The situation around Elo reinforces that point. Local media have periodically reported that Elo’s shareholders have evaluated strategic options, including a potential IPO, but there is no confirmed, publicly disclosed US IPO plan with hired banks and a defined timetable. That said, ongoing market interest in such companies is another sign of momentum in the broader Brazilian equity capital markets conversation.
For investors, the split venue strategy matters. Brazilian companies can use US listings to reach larger pools of capital and tighter price discovery. Meanwhile, a stronger B3 pipeline would deepen domestic liquidity and widen access for local funds. Both outcomes support the same broader trend: Brazilian growth companies are re-entering public markets after a long pause.
The next few quarters will show whether that flow stays abroad or returns home. Investors should watch whether more Brazilian issuers choose B3, or whether the next phase of the Brazilian IPO rebound still belongs to US exchanges.
